Search all trials

Find therapies in clinical trials near you – page 11

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Graves' disease

Not recruiting

Registered drug

Study on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease

Registered drug

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Deep vein thrombosis+1

Not recruiting

Registered drug

Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Bay 3018250

Contact Research Centre

Plasma cell myeloma

Not recruiting

InvestigationalNo placebo

Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Pleural mesothelioma

Not recruiting

Registered drugNo placebo

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Registered drug

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Registered drug

Italy

Participants:0–17 years · 18–64 years

Contact Research Centre

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Not recruiting

Registered drugNo placebo

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Aminocaproic Acid

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Congenital generalised lipodystrophy

Not recruiting

Registered drugNo placebo

Study on Metreleptin for Children Under 6 with Generalized Lipodystrophy and Related Diabetes or High Triglycerides

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Metreleptin

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

Marginal zone lymphoma+1

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 11

133 trials match your criteria

Plasma cell myeloma refractory

Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Graves' disease

Study on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease

Deep vein thrombosis+1

Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

Plasma cell myeloma

Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma

Pleural mesothelioma

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Type 1 diabetes mellitus

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Non-small cell lung cancer

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Congenital generalised lipodystrophy

Study on Metreleptin for Children Under 6 with Generalized Lipodystrophy and Related Diabetes or High Triglycerides

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Marginal zone lymphoma+1

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Non-small cell lung cancer

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.